AST's risk is mostly sequencing, not concept failure. The company likely has real demand and real technical differentiation, but the equity outcome still depends on converting launches,
commissioning, approvals, and carrier contracts into recurring revenue before capital intensity, competition, or bargaining pressure dilute the payoff.